10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
PFIZER INC | ||
Ticker: PFE Fiscal Year: 2011 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2011 10-K (Filed: Feb 28, 2012) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2011 | Dec 31, 2010 | |
| Assets | ||
| Cash and cash equivalents | $ 3,539 | 1,735 |
| Short-term investments | 23,219 | 26,277 |
| Accounts receivable, less allowance for doubtful accounts: 2011-$227; 2010-$208 | 13,608 | 13,380 |
| Short-term loans | 51 [1] | 467 |
| Inventories | 7,769 [2] | 8,275 |
| Taxes and other current assets | 9,441 | 9,440 |
| Assets of discontinued operations and other assets held for sale | 101 | 1,439 |
| Total current assets | 57,728 | 61,013 |
| Long-term investments and loans | 9,457 | 9,747 |
| Property, plant and equipment, less accumulated depreciation | 16,938 [3] | 18,645 |
| Goodwill | 45,067 | 43,928 [4] |
| Identifiable intangible assets, less accumulated amortization | 53,833 | 57,555 |
| Taxes and other noncurrent assets | 4,979 | 4,126 |
| Total assets | 188,002 | 195,014 |
| Liabilities and Shareholders' Equity | ||
| Short-term borrowings, including current portion of long-term debt: 2011-$6; 2010-$3,502 | 4,018 [5] | 5,603 |
| Accounts payable | 3,836 | 3,994 |
| Dividends payable | 1,796 | 1,601 |
| Income taxes payable | 1,013 | 951 |
| Accrued compensation and related items | 2,169 | 2,080 |
| Other current liabilities | 15,237 | 14,256 |
| Liabilities of discontinued operations | 151 | |
| Total current liabilities | 28,069 | 28,636 |
| Long-term debt | 34,931 [6] | 38,410 |
| Pension benefit obligations | 6,355 | 6,194 |
| Postretirement benefit obligations | 3,344 | 3,035 |
| Noncurrent deferred tax liabilities | 19,597 | 18,628 |
| Other taxes payable | 6,886 | 6,245 |
| Other noncurrent liabilities | 6,199 | 5,601 |
| Total liabilities | 105,381 | 106,749 |
| Commitments and Contingencies | ||
| Preferred stock, without par value, at stated value; 27 shares authorized; issued: 2011- 1,112; 2010-1,279 | 45 | 52 |
| Common stock, $0.05 par value; 12,000 shares authorized; issued: 2011-8,902; 2010-8,876 | 445 | 444 |
| Additional paid-in capital | 71,423 | 70,760 |
| Employee benefit trusts | (3) | (7) |
| Treasury stock, shares at cost; 2011-1,327; 2010-864 | (31,801) | (22,712) |
| Retained earnings | 46,210 | 42,716 |
| Accumulated other comprehensive loss | (4,129) | (3,440) |
| Total Pfizer Inc. shareholders' equity | 82,190 | 87,813 |
| Equity attributable to noncontrolling interests | 431 | 452 |
| Total shareholders' equity | 82,621 | 88,265 |
| Total liabilities and shareholders' equity | 188,002 | 195,014 |
| [3] The decrease in total property, plant and equipment is primarily due to depreciation, disposals and impairments, partially offset by capital additions, the impact of foreign exchange and the acquisition of King (see Note 2B. Acquisitions, Divestitures, Collaborative Arrangements and Equity-Method Investments: Acquisition of King Pharmaceuticals, Inc.). | ||
| [4] Beginning in the first quarter of 2011, our Company is managed through five operating segments, as shown in the table above (see also Note 18. Segment, Product and Geographic Area Information for further discussion about the change in management approach). As part of the change, we have retrospectively presented goodwill according to the new operating segment structure. | ||
| [5] The differences between the estimated fair values and carrying values of these financial assets and liabilities not measured at fair value on a recurring basis were not significant as of December 31, 2011 or December 31, 2010. | Includes foreign currency borrowings with fair values of $2 billion at December 31, 2010, which are used as hedging instruments. | ||
| [6] Includes foreign currency debt with fair values of $919 million at December 31, 2011 and $880 million at December 31, 2010, which are used as hedging instruments. | The fair value of our long-term debt is $40.1 billion at December 31, 2011 and $42.3 billion at December 31, 2010. | ||
| [1] Our short-term and long-term loans are due from companies with highly rated securities (Standard & Poor's (S&P) ratings that are virtually all AA or better). | ||
| [2] The decrease in total inventories is primarily due to the inventory sold during 2011 that was acquired from Wyeth and had been recorded at fair value, partially offset by the acquisition of King (see Note 2B. Acquisitions, Divestitures, Collaborative Arrangements and Equity-Method Investments: Acquisition of King Pharmaceuticals, Inc.) and the impact of foreign exchange. | Certain amounts of inventories are in excess of one year's supply. There are no recoverability issues associated with those amounts. | ||
| External Links | |
| PFIZER INC (PFE) Fiscal Year 2011 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |